Literature DB >> 29541877

Is your autonomic function good enough to be an Olympian? And other updates on recent autonomic research.

Mitchell G Miglis1, Srikanth Muppidi2.   

Abstract

Keywords:  Alpha-synucleinopathy; Autonomic Nervous System Index; β2-Adrenoreceptor

Mesh：

Substances：

Year:  2018        PMID： 29541877     DOI： 10.1007/s10286-018-0521-3

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN： 0959-9851            Impact factor:   4.435


× No keyword cloud information.
  5 in total

1.  Can the use of a single integrated unitary autonomic index provide early clues for eventual eligibility for olympic games?

Authors:  Daniela Lucini; Roberto Sala; Antonio Spataro; Mara Malacarne; Manuela Benzi; Stefano Tamorri; Massimo Pagani
Journal:  Eur J Appl Physiol       Date:  2018-02-15       Impact factor: 3.078

2.  β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson's disease.

Authors:  Shuchi Mittal; Kjetil Bjørnevik; Doo Soon Im; Adrian Flierl; Xianjun Dong; Joseph J Locascio; Kristine M Abo; Elizabeth Long; Ming Jin; Bing Xu; Yang K Xiang; Jean-Christophe Rochet; Anders Engeland; Patrizia Rizzu; Peter Heutink; Tim Bartels; Dennis J Selkoe; Barbara J Caldarone; Marcie A Glicksman; Vikram Khurana; Birgitt Schüle; David S Park; Trond Riise; Clemens R Scherzer
Journal:  Science       Date:  2017-09-01       Impact factor: 47.728

3.  Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication.

Authors:  D W Miller; S M Hague; J Clarimon; M Baptista; K Gwinn-Hardy; M R Cookson; A B Singleton
Journal:  Neurology       Date:  2004-05-25       Impact factor: 9.910

Review 4.  Prying into the Prion Hypothesis for Parkinson's Disease.

Authors:  Patrik Brundin; Ronald Melki
Journal:  J Neurosci       Date:  2017-10-11       Impact factor: 6.167

5.  Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson's disease patients.

Authors:  Ariadna Recasens; Iria Carballo-Carbajal; Annabelle Parent; Jordi Bové; Ellen Gelpi; Eduardo Tolosa; Miquel Vila
Journal:  Acta Neuropathol Commun       Date:  2018-02-08       Impact factor: 7.801
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.